Overview

Montelukast in Seasonal Allergic Rhinitis - Fall 1999 Study (0476A-117)

Status:
Completed
Trial end date:
1999-11-01
Target enrollment:
Participant gender:
Summary
This study will evaluate the ability of oral montelukast/loratadine to improve the signs and symptoms of seasonal allergic rhinitis compared with loratadine alone, montelukast alone and placebo.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Loratadine
Montelukast